https://www.taxtmi.com/caselaws?id=74570 Section 26A of the Drugs and Cosmetics Act permits prohibition of a drug only where the Central Government's satisfaction is founded on relevant material showing risk, lack of therapeutic value, or absence of therapeutic justification, and where prohibition is necessary in public interest. The ban on the fixed dose combination of corticosteroids with bronchodilators for internal use was found unsustainable because the record did not show that the required material, such as medical literature, clinical data, or other reliable information, had been placed before and considered by the Board before recommendation of the ban. The earlier governmental view that the combination was beneficial for bronchial asthma reinforced the absence of a demonstrated basis for the change in stance. en-us Sun, 21 Feb 1988 00:00:00 +0530 Thu, 18 Aug 2011 16:33:00 +0530 TaxTMI RSS Generator https://www.taxtmi.com/caselaws?id=74570 Section 26A of the Drugs and Cosmetics Act permits prohibition of a drug only where the Central Government's satisfaction is founded on relevant material showing risk, lack of therapeutic value, or absence of therapeutic justification, and where prohibition is necessary in public interest. The ban on the fixed dose combination of corticosteroids with bronchodilators for internal use was found unsustainable because the record did not show that the required material, such as medical literature, clinical data, or other reliable information, had been placed before and considered by the Board before recommendation of the ban. The earlier governmental view that the combination was beneficial for bronchial asthma reinforced the absence of a demonstrated basis for the change in stance. Case-Laws Central Excise Sun, 21 Feb 1988 00:00:00 +0530 https://www.taxtmi.com/caselaws?id=74570